| abstract |
This invention relates to compounds of formula (I), wherein one of R6, R7 and R8 is formula (II) and X, Y1 to Y4, R1 to R14 and n are as defined in the description, and to all enantiomers and pharmaceutically acceptable salts and/or esters thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are modulated by PPARĪ“ and/or PPARĪ± agonists. |